Department of Gastroenterology, Zhongnan Hospital of Wuhan University School of Medicine, Donghu Road 169, Wuhan, 430071, Hubei, People's Republic of China.
Cell Biochem Biophys. 2014 Jan;68(1):83-95. doi: 10.1007/s12013-013-9696-3.
The present study is to investigate effects of total glucosides of peony (TGP) on 2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol-induced colitis in rats and to explore potential clinical use of TGP for treatment of inflammatory bowel disease. Sixty Sprague-Dawley rats were randomly grouped into normal controls, model controls, sulfasalazine (SASP) controls (100 mg/kg/day), and low, medium, and high-dose TGP groups (25, 50, and 100 mg/kg/day, respectively). 24 h following colonic instillation of TNBS, TGP, and SASP were given by gastric gavage three times a day for 7 days. Disease activity index (DAI), colon macroscopic damage index (CMDI), histopathological score (HPS), and myeloperoxidase (MPO) activity were evaluated. Levels of serum TNF-α, IL-1β, and IL-10 were measured by ELISA, and expression of TNF-α, IL-1β, and IL-10 mRNA and protein in colonic tissues was detected by RT-PCR and western blot, respectively. Compared with rats in the model controls, TGP (50 or 100 mg/kg/day)-treated rats with TNBS/ethanol-induced colitis showed significant improvements of DAI, CMDI, HPS, and MPO activity. Moreover, administration of TGP (50 or 100 mg/kg/day) decreased the up-regulated levels of serum TNF-α and IL-1β, and expression of TNF-α and IL-1β mRNA and protein in colonic tissues, and increased the serum IL-10 and colonic IL-10 mRNA and protein level. And there was no significant difference compared with administration of SASP (P > 0.05). TGP attenuates TNBS/ethanol-induced colitis in rats and its efficacy is similar to SASP, the potential mechanism might be related to the adjustment of Th1/Th2 cytokines polarization by decreasing pro-inflammatory cytokine TNF-α and IL-1β, and increasing anti-inflammatory cytokine IL-10.
本研究旨在探讨白芍总苷(TGP)对 2,4,6-三硝基苯磺酸(TNBS)/乙醇诱导的大鼠结肠炎的影响,并探讨 TGP 治疗炎症性肠病的潜在临床应用。将 60 只 Sprague-Dawley 大鼠随机分为正常对照组、模型对照组、柳氮磺胺吡啶(SASP)对照组(100mg/kg/天)和低、中、高剂量 TGP 组(25、50 和 100mg/kg/天)。TNBS 结肠灌胃后 24 小时,TGP 和 SASP 通过胃灌胃每天三次给药,共 7 天。评估疾病活动指数(DAI)、结肠大体损伤指数(CMDI)、组织病理学评分(HPS)和髓过氧化物酶(MPO)活性。通过 ELISA 测定血清 TNF-α、IL-1β 和 IL-10 水平,通过 RT-PCR 和 Western blot 分别检测结肠组织中 TNF-α、IL-1β 和 IL-10 mRNA 和蛋白的表达。与模型对照组大鼠相比,TNBS/乙醇诱导结肠炎的 TGP(50 或 100mg/kg/天)治疗大鼠的 DAI、CMDI、HPS 和 MPO 活性均显著改善。此外,TGP(50 或 100mg/kg/天)给药降低了血清 TNF-α 和 IL-1β 以及结肠组织中 TNF-α 和 IL-1β mRNA 和蛋白的上调水平,并增加了血清 IL-10 和结肠组织中 IL-10 mRNA 和蛋白水平。与 SASP 给药相比无显著差异(P>0.05)。TGP 减轻 TNBS/乙醇诱导的大鼠结肠炎,其疗效与 SASP 相似,其潜在机制可能与通过降低促炎细胞因子 TNF-α和 IL-1β、增加抗炎细胞因子 IL-10 来调节 Th1/Th2 细胞因子极化有关。
Can J Physiol Pharmacol. 2008-12
J Gastroenterol Hepatol. 2009-5
J Ethnopharmacol. 2011-8-19
Biomed Pharmacother. 2016-4-28
Mitochondrial DNA B Resour. 2021-3-11
Front Pharmacol. 2020-7-10
J Cell Mol Med. 2018-11-24
Evid Based Complement Alternat Med. 2017